评估急性白血病中血栓栓塞风险的挑战:临床分析和当前评分系统的局限性
Luisa V Carvalho1, José Vanildo R de Oliveira1, Raphael B Melo1
1Division of Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
血栓事件发生在15.8%新诊断的急性白血病患者中,主要发生在诊断后30天内. 目前的预测得分对于这个高风险群体来说并不有效.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 血栓形成研究研究
背景情况:
- 关于新诊断的急性白血病 (AL) 发生血栓事件的危险因素的数据有限.
- 现有的血栓形成预测工具需要在AL患者中进一步验证.
研究的目的:
- 为了确定新诊断的AL患者中血栓形成的发病率.
- 在这个人群中验证已建立的血栓事件预测得分.
主要方法:
- 在2009年至2022年期间诊断出421名AL患者的回顾性分析.
- 收集从入院到60天随访期间有关静脉和动脉血栓事件的数据.
- 将Khorana,ISTH-DIC和Siriraj分数应用于队列.
主要成果:
- 血栓事件的累积60天发生率为15.8%,在急性淋巴细胞白血病 (21%) 中更高.
- 大多数事件 (72%) 发生在30天内;表面静脉和导管相关血栓形成最常见.
- 肥胖和高血小板计数与整体血栓形成风险有关;在AML中,爆发百分比和CRP有关. 预测得分显示没有关联.
结论:
- 在新诊断的AL患者中,血栓事件很常见,特别是在诱导期间.
- 目前的预测得分对于这个人群来说是不够的.
- 需要进一步的研究和新的生物标志物来改善AL的血栓形成预测.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
相关概念视频
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
